APA (7th ed.) Citation

ES, T., JM, L., JM, D., S, G., D, L., S, H., . . . HF, K. (2020). Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases. Canadian journal of gastroenterology & hepatology, 2020, 5104082. https://doi.org/10.1155/2020/5104082

Chicago Style (17th ed.) Citation

ES, Tsang, Loree JM, Davies JM, Gill S, Liu D, Ho S, Renouf DJ, Lim HJ, and Kennecke HF. "Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases." Canadian Journal of Gastroenterology & Hepatology 2020 (2020): 5104082. https://doi.org/10.1155/2020/5104082.

MLA (9th ed.) Citation

ES, Tsang, et al. "Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases." Canadian Journal of Gastroenterology & Hepatology, vol. 2020, 2020, p. 5104082, https://doi.org/10.1155/2020/5104082.